Lv5
928 积分 2024-08-19 加入
Global and regional cancer burden attributable to modifiable risk factors to inform prevention
4个月前
已完结
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity
6个月前
已完结
Mechanisms of genomic resistance across emerging classes of KRAS inhibitors
9个月前
已完结
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
9个月前
已完结
KRAS degradation averts PDAC chemoresistance
9个月前
已完结
Dual Inhibitors of KRASG12D and HSP90 are Effective Against KRASG12D Inhibitor Resistance
9个月前
已完结
PP01.06 Aurora Kinase A Inhibition Potentiates KRASG12C Inhibition and Overcomes Resistance to Sotorasib in Lung Cancer
10个月前
已关闭
Data from The KRAS<sup>G12C</sup> Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
10个月前
已完结
Response and Resistance to RAS Inhibition in Cancer
11个月前
已完结
PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
1年前
已完结